Dose testing study of a new skin-scar treatment in healthy adults
Part of Injuries & trauma, Skin clinical trials.
This Phase 2 study tests the dosing schedule of SLI-F06 in healthy volunteers. It may help researchers learn the safest dose and how well the treatment affects wound/scar-related healing after controlled study procedures.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be a healthy adult age 18 to 65.
- Your body weight/size must fit a BMI of 18.5 to 30 (and at least 40 kg).
- Your upper back (shoulder-blade area) must be shaped in a specific left/right symmetric way with enough space between the sides.
- You must be able to follow study instructions and likely attend all study visits.
- You must sign consent forms, including permission for photos/video.
- You must not have conditions or medicine use that could interfere with wound healing or safety (like pregnancy, blood thinners, vaping in the last 12 months, or recent steroids).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests an experimental injection (9MW3811) to help improve the appearance and feel of thick, raised scars that haven't improved on their own in at least 6 months. The treatment may reduce redness, firmness, and other signs of abnormal scarring.
This study tests a combination of two procedures: injecting your own fat (nanofat) into depressed scars and treating them with a special laser (fractional CO2 laser). The goal is to see if this combination improves the look of scars left by injuries better than laser alone.
This study tests a cream called SOF-SKN on healthy people to see if it's safe and how the body handles it. It is a first-in-human trial, so if you join, you'll help researchers learn about the cream before testing it in patients.
This trial tests a gel called FS2 applied after skin graft surgery for burns. It aims to see if the gel can help scars heal better and look less noticeable.
This trial tests whether a tiny “micro-coring” device can improve the look of scars. It enrolls adults with certain skin types who have not recently treated the scar and who can safely use numbing medicine used in the procedure.
This trial tests a special gel designed to prevent raised, thick scars (hypertrophic scars) after surgery or injury. If you have a new scar from a C-section, breast implant, or clean cut, this study may help reduce scarring.
Hear when a new Scar trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.